265 results on '"Romney, Marc G."'
Search Results
2. The Resurgence of Lymphogranuloma Venereum: Changing Presentation of Lymphogranuloma Venereum in the Era of HIV Preexposure Prophylaxis, 2004 to 2022
3. The resurgence of lymphogranuloma venereum (LGV): changing presentation of LGV in the era of HIV pre-exposure prophylaxis (PrEP), 2004-2022
4. Epidemiology of cytomegalovirus antiviral resistance testing for solid organ and bone marrow transplant patients from 2011 – 2019
5. Melting curve analysis reveals false-positive norovirus detection in a molecular syndromic panel
6. T-Cell Responses to COVID-19 Vaccines and Breakthrough Infection in People Living with HIV Receiving Antiretroviral Therapy
7. Antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapy
8. SARS-CoV-2 live virus neutralization after four COVID-19 vaccine doses in people with HIV receiving suppressive antiretroviral therapy
9. Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy
10. Rapid Increase in SARS-CoV-2 P.1 Lineage Leading to Codominance with B.1.1.7 Lineage, British Columbia, Canada, January-April 2021
11. Testing the limits of multiplex respiratory virus assays for SARS-CoV-2 at high cycle threshold values: Comparative performance of cobas 6800/8800 SARS-CoV-2 & Influenza A/B, Xpert Xpress SARS-CoV-2/Flu/RSV, and cobas Liat SARS-CoV-2 & Influenza A/B
12. Automated molecular testing of saliva for SARS-CoV-2 detection
13. Rapid Detection of SARS-CoV-2 Variants of Concern, Including B.1.1.28/P.1, British Columbia, Canada
14. Practical challenges to the clinical implementation of saliva for SARS-CoV-2 detection
15. Proteomic applications in pathology and laboratory medicine: Present state and future prospects
16. WGS of a cluster of MDR Shigella sonnei utilizing Oxford Nanopore R10.4.1 long-read sequencing
17. Effects of COVID-19 mRNA vaccination on HIV viremia and reservoir size
18. Hydrogel-embedded gold nanorods activated by plasmonic photothermy with potent antimicrobial activity
19. Phenotypic and Genotypic Correlates of Penicillin Susceptibility in Nontoxigenic Corynebacterium diphtheriae, British Columbia, Canada, 2015-2018
20. Humoral Response Following 3 Doses of mRNA COVID-19 Vaccines in Patients With Non-Dialysis-Dependent CKD: An Observational Study.
21. WGS of a cluster of MDR Shigella sonnei utilizing Oxford Nanopore R10.4.1 long-read sequencing.
22. Dynamics of T-cell responses following COVID-19 mRNA vaccination and breakthrough infection in older adults
23. Clinical heterogeneity of patients with stool samples testing PCR+/Tox− from a two-step Clostridium difficile diagnostic algorithm
24. No Isolate, No Problem: Using a Novel Insertion Sequence PCR to Link Rats to Human Shigellosis Cases in an Underserved Urban Community
25. Reduction in hospital-associated methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus with daily chlorhexidine gluconate bathing for medical inpatients
26. Testing the limits of multiplex respiratory virus assays for SARS-CoV-2 at high cycle threshold values: Comparative performance of cobas 6800/8800 SARS-CoV-2 & Influenza A/B, Xpert Xpress SARS-CoV-2/Flu/RSV, and cobas Liat SARS-CoV-2 & Influenza A/B.
27. Adaptability of single-nucleotide polymorphism-polymerase chain reaction (SNP-PCR) for subtyping SARS-CoV-2 and a new SNP-PCR for XBB, XBB.1.5, and B.Q.1/B.Q.1.1
28. Prediction of SARS-CoV-2 transmission dynamics based on population-level cycle threshold values: A Machine Learning and mechanistic modeling study
29. Impact of Age and Severe Acute Respiratory Syndrome Coronavirus 2 Breakthrough Infection on Humoral Immune Responses After Three Doses of Coronavirus Disease 2019 mRNA Vaccine
30. Determining the Longitudinal Serologic Response to COVID-19 Vaccination in the Chronic Kidney Disease Population: A Clinical Research Protocol
31. sj-docx-1-cjk-10.1177_20543581231160511 – Supplemental material for Determining the Longitudinal Serologic Response to COVID-19 Vaccination in the Chronic Kidney Disease Population: A Clinical Research Protocol
32. Retrospective cohort study of inappropriate piperacillin-tazobactam use for lower respiratory tract and skin and soft tissue infections: Opportunities for antimicrobial stewardship
33. Antibody response durability following three-dose COVID-19 vaccination in people with HIV receiving suppressive ART
34. Serial infection with SARS-CoV-2 Omicron BA.1 and BA.2 following three-dose COVID-19 vaccination
35. Omicron (B.1.1.529) SARS-CoV-2 viral load among nasopharyngeal and oral samples compared to other variants of concern and impact on diagnostic testing strategy
36. Impact of age and SARS-CoV-2 breakthrough infection on humoral immune responses after three doses of COVID-19 mRNA vaccine
37. Automated Library Construction and Analysis for High-throughput Nanopore Sequencing of SARS-CoV-2
38. People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose Responses
39. Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third Dose
40. People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responses
41. Large Community Outbreak of Streptococcus pneumoniae Serotype 5 Invasive Infection in an Impoverished, Urban Population
42. Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older Adults
43. Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy
44. Reduced magnitude and durability of humoral immune responses by COVID-19 mRNA vaccines among older adults
45. Next-generation sequencing for cytomegalovirus antiviral resistance genotyping in a clinical virology laboratory
46. SARS-CoV-2 RNA Quantification Using Droplet Digital RT-PCR
47. Repeat virological and serological profiles in hospitalized patients initially tested by nasopharyngeal RT‐PCR for SARS‐CoV‐2
48. Automated Library Construction and Analysis for High-Throughput Nanopore Sequencing of SARS-CoV-2 .
49. Qualitative evaluation and economic estimates of an infection control champions program
50. Microchip RT-PCR Detection of Nasopharyngeal SARS-CoV-2 Samples
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.